Plaintiffs Fight Privilege Claim In Neurontin Case
By Ben James ( February 22, 2010, 2:13 PM EST) -- Direct purchaser plaintiffs accusing Pfizer Inc. and a subsidiary of blocking generic competition for the epilepsy drug Neurontin by filing baseless patent litigation want a federal judge to look for evidence of crime or fraud in documents allegedly covered by attorney-client privilege....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.